Loading...

Doctor Care Anywhere Group PLC

DOC.AX•ASX
Healthcare
Medical - Healthcare Information Services
A$0.12
A$0.01(9.52%)

Doctor Care Anywhere Group PLC (DOC.AX) Stock Overview

Explore Doctor Care Anywhere Group PLC’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 65.0/100

Key Financials

Market Cap42.2M
P/E Ratio-3.25
EPS (TTM)$-0.03
ROE-5.56%
Fundamental Analysis

AI Price Forecasts

1 Week$0.11
1 Month$0.12
3 Months$0.07
1 Year Target$0.03

DOC.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Doctor Care Anywhere Group PLC (DOC.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.03, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.03.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -3.25 and a market capitalization of 42.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

62.03RSI (14)
0.00MACD
36.54ADX
Revenue Growth
2.26%
↑ 2.26%
Profit Growth
A$-0.02
↑ 37.40%
EPS Growth
A$-0.02
↑ 26.91%
Operating Margin
-11.59%
↑ 45.73%
ROE
-555.99%
↑ 37.40%
Dividend Yield
0.00%
Analyst Recommendations data is not available for DOC.AXAnalyst Recommendations details for DOC.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Doctor Care Anywhere Group PLC, together with its subsidiaries, provides digital healthcare and development services in the United Kingdom, Australia, and the Republic of Ireland. It offers services in the areas of appointments, patient records, prescriptions, referrals and fit notes, service improvements, and virtual GP consultations in the form of video and phone. The company provides treatments for allergies, bites and stings, cold and flu, headaches and migraines, joint pains, lifestyle support, mental and sexual health, skin conditions, and stomach and digestive problems, as well as offers virtual healthcare, technology platform licensing, and digital design services. It serves medical insurers, employers, retailers, healthcare providers, and direct sales to the public. The company was incorporated in 2013 and is headquartered in London, the United Kingdom.

CEO

Laura O'Riordan

Employees

610

Headquarters

13-15 Bouverie Street, London

Founded

2020

Frequently Asked Questions

;